| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2006-08-13 06:36:08 UTC |
|---|
| Update Date | 2021-09-14 14:58:36 UTC |
|---|
| HMDB ID | HMDB0003882 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole |
|---|
| Description | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole, also known as alpha-ribazole-5'-p or 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole 5'-phosphate, belongs to the class of organic compounds known as benzimidazole ribonucleosides and ribonucleotides. These are nucleosides with a structure that consists of an imidazole moiety of benzimidazole is N-linked to a ribose (or deoxyribose). Nucleotides have a phosphate group linked to the C5 carbon of the ribose (or deoxyribose) moiety. N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole exists in all living organisms, ranging from bacteria to humans. N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make N1-(5-phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole a potential biomarker for the consumption of these foods. N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole. |
|---|
| Structure | CC1=CC2=C(C=C1C)N(C=N2)[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O InChI=1S/C14H19N2O7P/c1-7-3-9-10(4-8(7)2)16(6-15-9)14-13(18)12(17)11(23-14)5-22-24(19,20)21/h3-4,6,11-14,17-18H,5H2,1-2H3,(H2,19,20,21)/t11-,12-,13-,14+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 5,6-Dimethyl-1-alpha-D-ribofuranosylbenzimidazole 5'-phosphate | ChEBI | | alpha-Ribazole-5'-p | ChEBI | | ALPHA-RIBAZOLE-5'-phosphATE | ChEBI | | N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole | ChEBI | | N(1)-(5-Phosphoribosyl)-5,6-dimethylbenzimidazole | ChEBI | | PHOSPHORIC ACID mono-[5-(5,6-dimethyl-benzoimidazol-1-yl)-3,4-dihydroxy-tetrahydro-furan-2ylmethyl] ester | ChEBI | | alpha-Ribazole 5'-phosphate | Kegg | | 5,6-Dimethyl-1-a-D-ribofuranosylbenzimidazole 5'-phosphate | Generator | | 5,6-Dimethyl-1-a-D-ribofuranosylbenzimidazole 5'-phosphoric acid | Generator | | 5,6-Dimethyl-1-alpha-D-ribofuranosylbenzimidazole 5'-phosphoric acid | Generator | | 5,6-Dimethyl-1-α-D-ribofuranosylbenzimidazole 5'-phosphate | Generator | | 5,6-Dimethyl-1-α-D-ribofuranosylbenzimidazole 5'-phosphoric acid | Generator | | a-Ribazole-5'-p | Generator | | Α-ribazole-5'-p | Generator | | a-RIBAZOLE-5'-phosphate | Generator | | a-RIBAZOLE-5'-phosphoric acid | Generator | | alpha-RIBAZOLE-5'-phosphoric acid | Generator | | Α-ribazole-5'-phosphate | Generator | | Α-ribazole-5'-phosphoric acid | Generator | | N1-(5-Phospho-α-D-ribosyl)-5,6-dimethylbenzimidazole | Generator | | PHOSPHate mono-[5-(5,6-dimethyl-benzoimidazol-1-yl)-3,4-dihydroxy-tetrahydro-furan-2ylmethyl] ester | Generator | | a-Ribazole 5'-phosphate | Generator | | a-Ribazole 5'-phosphoric acid | Generator | | alpha-Ribazole 5'-phosphoric acid | Generator | | Α-ribazole 5'-phosphate | Generator | | Α-ribazole 5'-phosphoric acid | Generator | | alpha-Ribazole-5'-PO4 | HMDB | | N1-(5-phospho-alpha-delta-Ribosyl)-5,6-dimethylbenzimidazole | HMDB |
|
|---|
| Chemical Formula | C14H19N2O7P |
|---|
| Average Molecular Weight | 358.2836 |
|---|
| Monoisotopic Molecular Weight | 358.092987484 |
|---|
| IUPAC Name | {[(2R,3S,4R,5S)-5-(5,6-dimethyl-1H-1,3-benzodiazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid |
|---|
| Traditional Name | α-ribazole-5'-P |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=CC2=C(C=C1C)N(C=N2)[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O |
|---|
| InChI Identifier | InChI=1S/C14H19N2O7P/c1-7-3-9-10(4-8(7)2)16(6-15-9)14-13(18)12(17)11(23-14)5-22-24(19,20)21/h3-4,6,11-14,17-18H,5H2,1-2H3,(H2,19,20,21)/t11-,12-,13-,14+/m1/s1 |
|---|
| InChI Key | ZMRGXEJKZPRBPJ-SYQHCUMBSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzimidazole ribonucleosides and ribonucleotides. These are nucleosides with a structure that consists of an imidazole moiety of benzimidazole is N-linked to a ribose (or deoxyribose). Nucleotides have a phosphate group linked to the C5 carbon of the ribose (or deoxyribose) moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Nucleosides, nucleotides, and analogues |
|---|
| Class | Benzimidazole ribonucleosides and ribonucleotides |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzimidazole ribonucleosides and ribonucleotides |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1-ribofuranosylbenzimidazole
- Pentose phosphate
- Pentose-5-phosphate
- Glycosyl compound
- N-glycosyl compound
- Monosaccharide phosphate
- Pentose monosaccharide
- Benzimidazole
- Monoalkyl phosphate
- Monosaccharide
- N-substituted imidazole
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Benzenoid
- Azole
- Tetrahydrofuran
- Imidazole
- Heteroaromatic compound
- 1,2-diol
- Secondary alcohol
- Oxacycle
- Organoheterocyclic compound
- Azacycle
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organopnictogen compound
- Organic oxide
- Alcohol
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | -0.524 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 3.95 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.1182 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 6.3 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 385.6 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 789.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 222.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 72.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 164.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 57.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 346.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 281.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 755.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 622.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 249.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 667.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 146.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 216.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 713.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 402.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 389.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,1TMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O)[C@@H](O[Si](C)(C)C)[C@H]1O)C=N2 | 3033.7 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,1TMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O[Si](C)(C)C)C=N2 | 3013.0 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,1TMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C)[C@@H](O)[C@H]1O)C=N2 | 3124.3 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,2TMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O)[C@@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C=N2 | 2976.8 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,2TMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O)C=N2 | 3072.3 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,2TMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C)[C@@H](O)[C@H]1O[Si](C)(C)C)C=N2 | 3057.9 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,2TMS,isomer #4 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O)[C@H]1O)C=N2 | 3098.3 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C=N2 | 3052.5 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C=N2 | 3008.8 | Standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C=N2 | 3672.8 | Standard polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O)C=N2 | 3080.2 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O)C=N2 | 3006.0 | Standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O)C=N2 | 3460.6 | Standard polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O)[C@H]1O[Si](C)(C)C)C=N2 | 3065.6 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O)[C@H]1O[Si](C)(C)C)C=N2 | 3022.2 | Standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O)[C@H]1O[Si](C)(C)C)C=N2 | 3495.8 | Standard polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,4TMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C=N2 | 3081.7 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,4TMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C=N2 | 2994.3 | Standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,4TMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C=N2 | 3303.5 | Standard polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,1TBDMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C=N2 | 3310.0 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,1TBDMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3290.1 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,1TBDMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]1O)C=N2 | 3364.0 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,2TBDMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3487.6 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,2TBDMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C=N2 | 3558.2 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,2TBDMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3541.6 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,2TBDMS,isomer #4 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]1O)C=N2 | 3564.4 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TBDMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3709.7 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TBDMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3606.5 | Standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TBDMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3854.4 | Standard polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TBDMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C=N2 | 3734.2 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TBDMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C=N2 | 3558.6 | Standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TBDMS,isomer #2 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C=N2 | 3713.8 | Standard polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TBDMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3715.7 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TBDMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3570.7 | Standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,3TBDMS,isomer #3 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3748.5 | Standard polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,4TBDMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3880.9 | Semi standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,4TBDMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3677.8 | Standard non polar | 33892256 | | N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole,4TBDMS,isomer #1 | CC1=CC2=C(C=C1C)N([C@H]1O[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C=N2 | 3637.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole GC-MS (Non-derivatized) - 70eV, Positive | splash10-0002-9612000000-fb21cfa813df9fff3f0d | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole GC-MS (2 TMS) - 70eV, Positive | splash10-01vk-5943100000-cb128df76b1b27f96534 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 10V, Positive-QTOF | splash10-0002-0924000000-ca83b2cabb6f848fb606 | 2015-09-15 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 20V, Positive-QTOF | splash10-0002-1910000000-f1a785d3193f0d8ff5bc | 2015-09-15 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 40V, Positive-QTOF | splash10-0002-0900000000-047b40eca213cd9b3d4d | 2015-09-15 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 10V, Negative-QTOF | splash10-0a6s-7709000000-c0797f58260c9a1a6a6c | 2015-09-15 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 20V, Negative-QTOF | splash10-002b-8900000000-1229d2ae6136dbe43637 | 2015-09-15 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 40V, Negative-QTOF | splash10-004i-9200000000-e3828a9e7ec68e9998b4 | 2015-09-15 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 10V, Negative-QTOF | splash10-0a4i-3009000000-6535ffb46debd0ae1f34 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 20V, Negative-QTOF | splash10-004i-9001000000-578749d5ff31e4fab5ea | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 40V, Negative-QTOF | splash10-004i-9100000000-d4ee221347b2259634d2 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 10V, Positive-QTOF | splash10-0a4j-0719000000-2538d2d5f670e5ddcec9 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 20V, Positive-QTOF | splash10-0002-0923000000-40c17e787a25cabb848e | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole 40V, Positive-QTOF | splash10-0002-4900000000-6c85eaa5dbac4013d383 | 2021-09-25 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
|
|---|